Calcification inhibitors in rat and human serum and plasma.
Rat and human serum and plasma were shown to contain considerable amounts of calcium phosphate precipitation inhibitors. Two general classes of inhibiting molecules were observed for both species: high molecular weight (approx. 30 000-200 000) and low molecular weight (less than 1000). The high molecular weight components eluted from a Bio-Gel P-200 column in two peaks, one at approx. 158 000 and a broader peak at approx. 43 000. The identity of these inhibitors is unknown at present. Low molecular weight inhibitors include magnesium, pyrophosphate, and citrate ions and at least one unidentified component that coelutes with pyrophosphate and citrate on a Bio-Gel P-4 column. Quantitatively, most of the inhibitor activity resides in the high molecular weight components and it is possible that it is this activity which is responsible for maintaining the metastability of the circulating fluids. The role of the low molecular weight components may be to regulate calcification at sites inaccessible to high molecular weight molecules.
D000818:Animals; D002113:Calcification, Physiologic; D002130:Calcium Phosphates / Q000037:antagonists & inhibitors*; D011232:Chemical Precipitation; D002850:Chromatography, Gel; D002951:Citrates / Q000097:blood / Q000494:pharmacology; D019343:Citric Acid; D011756:Diphosphates / Q000097:blood / Q000494:pharmacology; D006801:Humans; D008274:Magnesium / Q000097:blood / Q000494:pharmacology; D008970:Molecular Weight; D051381:Rats
D002130:Calcium Phosphates; D002951:Citrates; D011756:Diphosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D019343:Citric Acid; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; D008274:Magnesium; C485829:calcium phosphate, dibasic, anhydrous